🟢 90/100

This product looks safe

  • Contains proprietary blend — exact ingredient amounts not disclosed
  • 75% of ingredients have research evidence
A Label Compliance Grade

Product Label

📸

Have a supplement label? Find it here.

Upload a photo of any supplement label to search our database of 92,312 products.

Safety Alerts

ℹ️ Contains proprietary blend — exact ingredient amounts not disclosed

Label Data

3 Vegetarian Capsule(s) Serving Size
10 Servings
Other Combinations Product Type
75% Evidence Coverage

Supplement Facts — Evidence Check

20 mg (100% DV)
✅ 1.4× RDA — within safe limits 📚 193 studies (Tier A: 5, B: 63)
RDA 14mg This product: 20mg UL 35mg
2 mg (100% DV)
✅ 1.5× RDA — within safe limits 📚 113 studies (Tier A: 3, B: 35)
RDA 1.3mg This product: 2mg UL 100mg
150 mg (38% DV)
📊 Market median: 4002.0mg (1 products) 📚 20 studies (Tier A: 0, B: 2)
This product: 150mg
Proprietary Sleep Blend
1500 mg

Other Ingredients

Hypromellose Cellulose Magnesium Stearate Silicon Dioxide

Label Claims — Verification

Nutrient
All Other
Structure/Function
All Other (97% of products) Structure/Function (86% of products) Nutrient (36% of products)

Target Groups

Adult (18 - 50 Years) Gluten Free Dairy Free

Product Information

📋 Directions for Use

Suggested Use As a dietary supplement, take 3 capsules preferably on an empty stomach, or as recommended by your qualified healthcare professional. Do not exceed 3 capsules in a 24 hour period.

⚠️ Warnings & Precautions

Caution When using this product do not drive a motor vehicle or operate machinery.

Warning: If you are pregnant, breastfeeding, on medication or have a known medical condition consult a qualified medical processional before taking relax.

Keep out of reach of children.

Do not use if seal under cap is broken or missing.

🧪 Formulation Notes

About A mix of nutrients, herbs long used in traditional medicines such as Ayurveda and neurotransmitter precursors such as 5-HTP to support relaxation.

All Weyland Brain Nutrition products are manufactured in the USA at an FDA inspected, cGMP compliant, and 3rd party rated facility.

A mix of nutrients, herbs from traditional medicines and neurotransmitter precursors to support relaxation.

Contains No: Dairy, fish, gluten, peanuts, shellfish, tree nuts, wheat or yeast. No artificial flavor or colors.

Gluten free

Additional Information

Recyclable bottle

Store in a cool, dry place.

Product Details

UPC / SKU X0028EMAWX
DSLD Entry Date 2022-05-19
Product Type Other Combinations
Form Capsule
DSLD ID 265234
Data Updated 2026-04-11

Research Evidence

241 Research Sources
55 Avg Quality Score
113 Meta Analysis
75 Systematic Review
32 Rct
11 Clinical Trial
3 Other
3 Regulatory Source
1 Cochrane Review
1 Narrative Review
1 Openfda Safety
A Niacin for primary and secondary prevention of cardiovascular events
Meta Analysis The Cochrane database of systematic reviews 2017
A Use of high potency statins and rates of admission for acute kidney injury: multicenter, retrospective observational analysis of administrative databases
Meta Analysis BMJ (Clinical research ed.) 2013
A Effect on cardiovascular risk of high density lipoprotein targeted drug treatments niacin, fibrates, and CETP inhibitors: meta-analysis of randomised controlled trials including 117,411 patients
Meta Analysis BMJ (Clinical research ed.) 2014
A A terminal metabolite of niacin promotes vascular inflammation and contributes to cardiovascular disease risk
Meta Analysis Nature medicine 2024
A Meta-analysis and imputation refines the association of 15q25 with smoking quantity
Meta Analysis Nature genetics 2010
A Genome-wide meta-analyses identify multiple loci associated with smoking behavior
Meta Analysis Nature genetics 2010
A Antidepressants for smoking cessation
Meta Analysis The Cochrane database of systematic reviews 2014
A Topical azelaic acid, salicylic acid, nicotinamide, sulphur, zinc and fruit acid (alpha-hydroxy acid) for acne
Meta Analysis The Cochrane database of systematic reviews 2020
B Assessment of the Role of Niacin in Managing Cardiovascular Disease Outcomes: A Systematic Review and Meta-analysis
Meta Analysis JAMA network open 2019
B Association Between Lowering LDL-C and Cardiovascular Risk Reduction Among Different Therapeutic Interventions: A Systematic Review and Meta-analysis
Meta Analysis JAMA 2016
View all evidence for Niacin →

Compare Similar Products

View all Niacin products →